- Home
- Publications
- Publication Search
- Publication Details
Title
Manufacturing Natural Killer Cells as Medicinal Products
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-11-15
DOI
10.3389/fimmu.2016.00504
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients
- (2016) A. Curti et al. CLINICAL CANCER RESEARCH
- Ex vivo expansion of natural killer cells from human peripheral blood mononuclear cells co-stimulated with anti-CD3 and anti-CD52 monoclonal antibodies
- (2016) Jun-ichi Masuyama et al. CYTOTHERAPY
- Natural killer cells blaze into immuno-oncology
- (2016) Ken Garber NATURE BIOTECHNOLOGY
- The "cancer immunogram"
- (2016) C. U. Blank et al. SCIENCE
- Induced Pluripotent Stem Cells Can Effectively Differentiate into Multiple Functional Lymphocyte Lineages In Vivo with Negligible Bias
- (2016) Tianshu Lan et al. STEM CELLS AND DEVELOPMENT
- Reconstitution of Natural Killer Cells in HLA-Matched HSCT after Reduced-Intensity Conditioning: Impact on Clinical Outcome
- (2015) Caroline Pical-Izard et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A novel method to expand large numbers of CD56+ natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation
- (2015) Sumithira Vasu et al. CYTOTHERAPY
- Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy
- (2015) Markus Granzin et al. CYTOTHERAPY
- Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients
- (2015) Susann Szmania et al. JOURNAL OF IMMUNOTHERAPY
- Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
- (2015) Kurt Schönfeld et al. MOLECULAR THERAPY
- Advantages and applications of CAR-expressing natural killer cells
- (2015) Wolfgang Glienke et al. Frontiers in Pharmacology
- Present and Future of Allogeneic Natural Killer Cell Therapy
- (2015) Okjae Lim et al. Frontiers in Immunology
- Utilizing Chimeric Antigen Receptors to Direct Natural Killer Cell Activity
- (2015) David L. Hermanson et al. Frontiers in Immunology
- How to outsmart NK cell tolerance
- (2015) Grzegorz Terszowski et al. OncoImmunology
- Potential of autologous NK cell therapy to eradicate leukemia
- (2015) Hisham Abdel-Azim et al. OncoImmunology
- Advances in clinical NK cell studies: Donor selection, manufacturing and quality control
- (2015) U. Koehl et al. OncoImmunology
- Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen–Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study
- (2014) Inpyo Choi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Expansion and Homing of Adoptively Transferred Human Natural Killer Cells in Immunodeficient Mice Varies with Product Preparation and In Vivo Cytokine Administration: Implications for Clinical Therapy
- (2014) Jeffrey S. Miller et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation
- (2014) N. N. Shah et al. BLOOD
- Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein
- (2014) V. Bachanova et al. BLOOD
- HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patients
- (2014) X-Y Zhao et al. BRITISH JOURNAL OF CANCER
- Guidelines for the use of cell lines in biomedical research
- (2014) R J Geraghty et al. BRITISH JOURNAL OF CANCER
- Infusions of Allogeneic Natural Killer Cells as Cancer Therapy
- (2014) W. Leung CLINICAL CANCER RESEARCH
- Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
- (2014) V. D. Kheav et al. HAEMATOLOGICA
- Donor Killer Cell Ig-like Receptor B Haplotypes, Recipient HLA-C1, and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous Leukemia
- (2014) S. Cooley et al. JOURNAL OF IMMUNOLOGY
- Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective
- (2014) Cristina Eguizabal et al. Frontiers in Immunology
- Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies
- (2013) H. E. Kohrt et al. BLOOD
- Umbilical cord blood transplantation: the first 25 years and beyond
- (2013) K. K. Ballen et al. BLOOD
- Treatment of patients with advanced cancer with the natural killer cell line NK-92
- (2013) Torsten Tonn et al. CYTOTHERAPY
- Effect of Donor KIR2DL1 Allelic Polymorphism on the Outcome of Pediatric Allogeneic Hematopoietic Stem-Cell Transplantation
- (2013) Rafijul Bari et al. JOURNAL OF CLINICAL ONCOLOGY
- Irradiated and Activated Autologous PBMCs Induce Expansion of Highly Cytotoxic Human NK Cells In Vitro
- (2013) Yong-Oon Ahn et al. JOURNAL OF IMMUNOTHERAPY
- GMP-Compliant, Large-Scale Expanded Allogeneic Natural Killer Cells Have Potent Cytolytic Activity against Cancer Cells In Vitro and In Vivo
- (2013) Okjae Lim et al. PLoS One
- Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity
- (2013) Nina Shah et al. PLoS One
- Engineered Human Embryonic Stem Cell-Derived Lymphocytes to Study In Vivo Trafficking and Immunotherapy
- (2013) David A. Knorr et al. STEM CELLS AND DEVELOPMENT
- Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
- (2013) David A. Knorr et al. Stem Cells Translational Medicine
- Bringing natural killer cells to the clinic: ex vivo manipulation
- (2013) R. W. Childs et al. Hematology-American Society of Hematology Education Program
- Development, Expansion, and In vivo Monitoring of Human NK Cells from Human Embryonic Stem Cells (hESCs) and and Induced Pluripotent Stem Cells (iPSCs)
- (2013) Allison M. Bock et al. Jove-Journal of Visualized Experiments
- Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity
- (2013) Laurent Boissel et al. OncoImmunology
- Clinical Grade Purification and Expansion of NK Cell Products for an Optimized Manufacturing Protocol
- (2013) Ulrike Koehl et al. Frontiers in Oncology
- A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
- (2012) N. Vey et al. BLOOD
- Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
- (2012) M Stern et al. BONE MARROW TRANSPLANTATION
- Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications
- (2012) Natalia Lapteva et al. CYTOTHERAPY
- Migration of iron-labeled KHYG-1 natural killer cells to subcutaneous tumors in nude mice, as detected by magnetic resonance imaging
- (2012) Christiane L. Mallett et al. CYTOTHERAPY
- Highly activated and expanded natural killer cells for multiple myeloma immunotherapy
- (2012) T. K. Garg et al. HAEMATOLOGICA
- HLA-C–Dependent Prevention of Leukemia Relapse by Donor ActivatingKIR2DS1
- (2012) Jeffrey M. Venstrom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells
- (2012) Andreas Lundqvist et al. Journal of Cancer
- NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions
- (2011) B. Foley et al. BLOOD
- Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
- (2011) A. Curti et al. BLOOD
- G-CSF downregulates natural killer cell-mediated cytotoxicity in donors for hematopoietic SCT
- (2011) Y-C Su et al. BONE MARROW TRANSPLANTATION
- Use of NK cell activity in cure by transplant
- (2011) Wing Leung BRITISH JOURNAL OF HAEMATOLOGY
- Adoptive Transfer of Autologous Natural Killer Cells Leads to High Levels of Circulating Natural Killer Cells but Does Not Mediate Tumor Regression
- (2011) M. R. Parkhurst et al. CLINICAL CANCER RESEARCH
- Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignancies
- (2011) Garnet Suck et al. EXPERIMENTAL HEMATOLOGY
- Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
- (2011) Jan Spanholtz et al. PLoS One
- Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
- (2010) S. Cooley et al. BLOOD
- Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients
- (2010) Uwe Siegler et al. CYTOTHERAPY
- Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor
- (2010) Tolga Sutlu et al. CYTOTHERAPY
- High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy
- (2010) Jan Spanholtz et al. PLoS One
- Donor KIR3DL1/3DS1 Gene and Recipient Bw4 KIR Ligand as Prognostic Markers for Outcome in Unrelated Hematopoietic Stem Cell Transplantation
- (2009) Katia Gagne et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The Notch Ligands Jagged2, Delta1, and Delta4 Induce Differentiation and Expansion of Functional Human NK Cells from CD34+ Cord Blood Hematopoietic Progenitor Cells
- (2009) Rose C. Beck et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine245
- (2009) R. Bari et al. BLOOD
- Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity
- (2009) P. S. Woll et al. BLOOD
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
- (2009) H. Fujisaki et al. CANCER RESEARCH
- Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells
- (2009) Maria Berg et al. CYTOTHERAPY
- Umbilical Cord Mesenchymal Stem Cells Increase Expansion of Cord Blood Natural Killer Cells
- (2008) Laurent Boissel et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components
- (2008) E. Alici et al. BLOOD
- Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
- (2008) S. Arai et al. CYTOTHERAPY
- The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease
- (2008) E. M. Dunbar et al. HAEMATOLOGICA
- Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells
- (2008) C. Vitale et al. INTERNATIONAL IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started